Product Program year 2019 Source: CMS Open Payments

Dasotraline

Drug Cns

Open in the dashboard

General payments

$143,430

241 payments

Research payments

$0

0 payments

Through program year 2019, $143,430 in general payments and $0 in research payments were reported against Dasotraline (Cns).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $143,430 241

Breakdown

Who paid General payments · program year 2019
  1. Sunovion Pharmaceuticals Inc. $143,430 241 payments
Top recipients General payments · program year 2019
  1. Gary Johnson Family Medicine · Madison, WI $13,101 9% · 16 payments
  2. Jeremy Gleeson Endocrinology, Diabetes & Metabolism · Albuquerque, NM $13,039 9% · 20 payments
  3. Gabriel Novoa Internal Medicine · Miami, FL $12,940 9% · 20 payments
  4. Marc Richmond Irvine, CA $12,825 9% · 16 payments
  5. Gregory Mattingley Psychiatry · Saint Charles, MO $9,104 6% · 13 payments

The top 5 of 25 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Psychiatry Psychiatry & Neurology $53,866 43% · 11 practitioners
  2. Family Medicine $22,277 18% · 4 practitioners
  3. Internal Medicine $18,561 15% · 2 practitioners
  4. Endocrinology, Diabetes & Metabolism Internal Medicine $17,032 14% · 2 practitioners
  5. Hospice and Palliative Medicine Family Medicine $4,375 4% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $31,271 22% · 6 recipients
  2. Florida $19,940 14% · 2 recipients
  3. New York $17,285 12% · 3 recipients
  4. New Mexico $13,039 9% · 1 recipient
  5. Michigan $12,921 9% · 3 recipients

The top 5 of 13 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

241 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record